Indirect clinical markers for the detection of anabolic steroid abuse beyond the conventional doping control in athletes

被引:20
作者
Christou, Georgios A. [1 ]
Christou, Maria A. [2 ]
Ziberna, Lovro [3 ,4 ]
Christou, Konstantinos A. [1 ]
机构
[1] Aristotle Univ Thessaloniki, Sports Med Div, Lab Sports Med, Ag Sofias Str 26, Thessaloniki 54622, Greece
[2] Univ Ioannina, Sch Med, Dept Endocrinol, Ioannina, Greece
[3] Univ Ljubljana, Inst Pharmacol & Expt Toxicol, Fac Med, Ljubljana, Slovenia
[4] Slovenian Antidoping Org SLOADO, Ljubljana, Slovenia
关键词
antidoping control; anabolic steroid abusers; diagnostic markers; DENSITY-LIPOPROTEIN CHOLESTEROL; SHORT QT INTERVAL; ANDROGENIC STEROIDS; INSULIN SENSITIVITY; PELIOSIS HEPATIS; TESTOSTERONE; NANDROLONE; LIPIDS; SERUM; APOLIPOPROTEINS;
D O I
10.1080/17461391.2019.1587522
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
Growing analytical challenges have arisen for the detection of misuse of androgenic anabolic steroids (AAS) in athletes the last years. Therefore, consideration of additional indirect markers can substantially aid the efforts to detect AAS abuse in athletes. Moreover, this approach can also help physicians to suspect AAS abuse when treating athletes. Laboratory markers highly indicative of AAS abuse in athletes include the considerable downregulation of high density lipoprotein-cholesterol, elevation of haematocrit or serum.-glutamyl transpeptidase levels and for males reduced serum levels of both luteinizing hormone and follicle-stimulating hormone. Moreover, physical signs suggestive of current AAS abuse are hypertension, apparent changes in behaviour making the athlete more irritable and aggressive and the sudden appearance of acne vulgaris in an adult athlete with no recent history of acne, while testicular atrophy and gynecomastia raise suspicion of current or past AAS abuse in male athletes.
引用
收藏
页码:1276 / 1286
页数:11
相关论文
共 66 条
[1]  
Alen M, 1985, Br J Sports Med, V19, P15
[2]   The Effect of Chronic Anabolic-Androgenic Steroid Use on Tp-E Interval, Tp-E/Qt Ratio, and Tp-E/Qtc Ratio in Male Bodybuilders [J].
Alizade, Elnur ;
Avci, Anil ;
Fidan, Serdar ;
Tabakci, Mustafa ;
Bulut, Mustafa ;
Zehir, Regayip ;
Simsek, Zeki ;
Evlice, Mert ;
Arslantas, Ugur ;
Cakir, Hakan ;
Emiroglu, Mehmet Yunus ;
Akcakoyun, Mustafa .
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2015, 20 (06) :592-600
[3]   Enhanced vasoconstriction and reduced vasorelaxation induced by testosterone and nandrolone in hypercholesterolemic rabbits [J].
Ammar, EM ;
Said, SA ;
Hassan, MS .
PHARMACOLOGICAL RESEARCH, 2004, 50 (03) :253-259
[4]   THE DYSLIPOPROTEINEMIA OF ANABOLIC-STEROID THERAPY - INCREASE IN HEPATIC TRIGLYCERIDE LIPASE PRECEDES THE DECREASE IN HIGH-DENSITY LIPOPROTEIN2 CHOLESTEROL [J].
APPLEBAUMBOWDEN, D ;
HAFFNER, SM ;
HAZZARD, WR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (10) :949-952
[5]  
Ayotte Christiane, 2010, Handb Exp Pharmacol, P77, DOI 10.1007/978-3-540-79088-4_4
[6]   ANDROGENS POTENTIATE THE EFFECTS OF ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA OF END-STAGE RENAL-DISEASE [J].
BALLAL, SH ;
DOMOTO, DT ;
POLACK, DC ;
MARCIULONIS, P ;
MARTIN, KJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (01) :29-33
[7]   Long-term anabolic steroids in male bodybuilders induce cardiovascular structural and autonomic abnormalities [J].
Barbosa Neto, Octavio ;
da Mota, Gustavo Ribeiro ;
De Sordi, Carla Cristina ;
Resende, Elisabete Aparecida M. R. ;
Resende, Luiz Antonio P. R. ;
Vieira da Silva, Marco Antonio ;
Marocolo, Moacir ;
Cortes, Rafael Silva ;
de Oliveira, Lucas Felipe ;
Dias da Silva, Valdo Jose .
CLINICAL AUTONOMIC RESEARCH, 2018, 28 (02) :231-244
[8]  
BERNS JS, 1992, CLIN NEPHROL, V37, P264
[9]  
Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/nejm199607043350101
[10]   Testosterone dose-response relationships in healthy young men [J].
Bhasin, S ;
Woodhouse, L ;
Casaburi, R ;
Singh, AB ;
Bhasin, D ;
Berman, N ;
Chen, XH ;
Yarasheski, KE ;
Magliano, L ;
Dzekov, C ;
Dzekov, J ;
Bross, R ;
Phillips, J ;
Sinha-Hikim, I ;
Shen, RQ ;
Storer, TW .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 281 (06) :E1172-E1181